Suppr超能文献

克罗恩病中的宿主-微生物组相互作用:一个常见还是家族性问题?

Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

作者信息

Michielan Andrea, D'Incà Renata

机构信息

Andrea Michielan, Renata D'Incà, Department of Surgical, Oncological and Gastroenterological Sciences, Azienda Ospedaliera - Università degli Studi di Padova, 35128 Padova, Italy.

出版信息

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):159-68. doi: 10.4291/wjgp.v6.i4.159.

Abstract

An impaired interaction between the gut and the intestinal microbiome is likely to be the key element in the pathogenesis of Crohn's disease (CD). Family studies have provided invaluable information on CD pathogenesis and on its etiology. Relatives share the same genetic risk of developing the disease as affected subjects. Relatives also exhibit similar features relating to their host-microbiome interaction, namely genetic variants in loci involved in detecting bacteria, a greater sero-reactivity to microbial components, and an impaired intestinal permeability. The burden of environmental factors such as cigarette smoking and dysbiosis also seems to be particularly relevant in these genetically predisposed subjects. Diet is emerging as an important factor and could account for the changing epidemiology of CD in recent years. Despite the pivotal role of genetics in the disease's pathogenesis (especially in familial CD), screening tests in healthy relatives cannot be recommended.

摘要

肠道与肠道微生物群之间的相互作用受损可能是克罗恩病(CD)发病机制的关键因素。家族研究为CD的发病机制及其病因提供了宝贵信息。亲属与患病个体具有相同的发病遗传风险。亲属在宿主与微生物群相互作用方面也表现出相似特征,即在参与检测细菌的基因座中存在基因变异、对微生物成分的血清反应性更强以及肠道通透性受损。吸烟和生态失调等环境因素的影响在这些具有遗传易感性的个体中似乎尤为显著。饮食正成为一个重要因素,可能是近年来CD流行病学变化的原因。尽管遗传学在该疾病的发病机制中起着关键作用(尤其是在家族性CD中),但不建议对健康亲属进行筛查检测。

相似文献

1
Host-microbiome interaction in Crohn's disease: A familiar or familial issue?
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):159-68. doi: 10.4291/wjgp.v6.i4.159.
2
Dysbiotic gut microbiome: A key element of Crohn's disease.
Comp Immunol Microbiol Infect Dis. 2015 Dec;43:36-49. doi: 10.1016/j.cimid.2015.10.005. Epub 2015 Oct 25.
3
The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
Gastroenterol Clin North Am. 2017 Sep;46(3):481-492. doi: 10.1016/j.gtc.2017.05.004. Epub 2017 Jul 19.
4
Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
Aliment Pharmacol Ther. 2006 May 15;23(10):1455-61. doi: 10.1111/j.1365-2036.2006.02916.x.
6
Role of environmental factors in the pathogenesis of Crohn's disease: a critical review.
Int J Colorectal Dis. 2019 Dec;34(12):2023-2034. doi: 10.1007/s00384-019-03441-9. Epub 2019 Nov 16.
7
A microbial signature for Crohn's disease.
Gut. 2017 May;66(5):813-822. doi: 10.1136/gutjnl-2016-313235. Epub 2017 Feb 7.
8
Epidemiology of Crohn's Disease.
J Clin Gastroenterol. 1986 Apr;8(2):160-5. doi: 10.1097/00004836-198604000-00011.
9
Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G420-G431. doi: 10.1152/ajpgi.00411.2017. Epub 2018 May 31.
10
The evidence for fungus in Crohn's disease pathogenesis.
Clin J Gastroenterol. 2018 Dec;11(6):449-456. doi: 10.1007/s12328-018-0886-9. Epub 2018 Jul 19.

引用本文的文献

2
Antcin-H, a natural triterpene derived from , ameliorates dextran sulfate sodium-induced colitis in mice by inhibiting the NLRP3 inflammasome.
J Tradit Complement Med. 2024 Mar 30;15(4):343-355. doi: 10.1016/j.jtcme.2024.03.016. eCollection 2025 Jul.
3
4
Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides.
Acta Physiol (Oxf). 2021 Jun;232(2):e13655. doi: 10.1111/apha.13655. Epub 2021 May 6.
5
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Autophagy. 2020 Jan;16(1):38-51. doi: 10.1080/15548627.2019.1635384. Epub 2019 Jul 9.

本文引用的文献

2
Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.
Inflamm Bowel Dis. 2015 Apr;21(4):879-87. doi: 10.1097/MIB.0000000000000323.
3
Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases.
Intest Res. 2015 Jan;13(1):11-8. doi: 10.5217/ir.2015.13.1.11. Epub 2015 Jan 29.
5
Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.
Autoimmun Rev. 2015 Mar;14(3):231-45. doi: 10.1016/j.autrev.2014.11.004. Epub 2014 Nov 13.
6
Intestinal permeability--a new target for disease prevention and therapy.
BMC Gastroenterol. 2014 Nov 18;14:189. doi: 10.1186/s12876-014-0189-7.
7
The history of genetics in inflammatory bowel disease.
Ann Gastroenterol. 2014;27(4):294-303.
8
Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice.
J Crohns Colitis. 2014 Dec;8(12):1710-22. doi: 10.1016/j.crohns.2014.08.008. Epub 2014 Sep 7.
10
The diagnostic approach to monogenic very early onset inflammatory bowel disease.
Gastroenterology. 2014 Nov;147(5):990-1007.e3. doi: 10.1053/j.gastro.2014.07.023. Epub 2014 Jul 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验